UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000031605
Receipt number R000036050
Scientific Title Study of longitudinal observation for patient with X-linked hypophosphatemic rickets/osteomalacia in collaboration with Asian partners
Date of disclosure of the study information 2018/04/20
Last modified on 2023/09/15 17:28:29

No. Disposal Last modified on Item of update
1 Insert 2018/03/06 14:54:10
2 Update 2018/03/30 16:12:03 Date of disclosure of the study information
3 Update 2018/04/11 13:39:58 Date of disclosure of the study information
4 Update 2018/04/19 14:30:21 Public title
Acronym
5 Update 2018/04/19 14:33:28 Acronym
Acronym
6 Update 2019/03/29 09:54:14 Key inclusion criteria
Key inclusion criteria
7 Update 2019/03/29 09:58:49 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Name of person sending information
Name of person sending information
Organization
Organization
Address
Address
Tel
Email
8 Update 2019/03/29 10:02:38 Recruitment status
Date of IRB
Last follow-up date
9 Update 2019/03/29 10:05:21
Last name of contact person
10 Update 2019/09/24 16:52:12 Name of person sending information
Name of person sending information
Organization
Organization
Email
Institute
Institute
Organization
Organization
11 Update 2020/03/10 16:19:28 Key exclusion criteria
Key exclusion criteria
12 Update 2020/03/11 10:50:45 1st name of lead principal investigator
Last name of lead principal investigator
Email
13 Update 2020/03/11 15:16:11 Post marketing survey by drug manufacture etc., specified by Japanese law.
14 Update 2020/03/11 17:24:05 Post marketing survey by drug manufacture etc., specified by Japanese law.
15 Update 2020/09/16 08:49:04 URL releasing protocol
16 Update 2020/09/16 08:51:45 Address
Address
TEL
17 Update 2020/09/16 08:53:52 Organization
18 Update 2021/03/16 13:24:14 Target sample size
19 Update 2023/03/10 15:37:28 Narrative objectives1
Narrative objectives1
20 Update 2023/03/10 15:39:03 Key inclusion criteria
Key inclusion criteria
21 Update 2023/03/10 15:42:21 Recruitment status
Last follow-up date
Other related information
Other related information
22 Update 2023/09/15 17:28:29 Number of participants that the trial has enrolled